Al Aqar Healthcare Stock Earnings Per Share
| 5116 Stock | 1.36 0.02 1.45% |
Al Aqar Healthcare fundamentals help investors to digest information that contributes to Al Aqar's financial success or failures. It also enables traders to predict the movement of 5116 Stock. The fundamental analysis module provides a way to measure Al Aqar's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Al Aqar stock.
5116 |
Al Aqar Healthcare Company Earnings Per Share Analysis
Al Aqar's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
| Competition |
According to the company disclosure, Al Aqar Healthcare has an Earnings Per Share of 0.0 times. This is 100.0% lower than that of the Real Estate sector and about the same as Residential & Commercial REITs (which currently averages 0.0) industry. The earnings per share for all Malaysia stocks is 100.0% higher than that of the company.
Did you try this?
Run Premium Stories Now
Premium StoriesFollow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
| All Next | Launch Module |
5116 Fundamentals
| Return On Equity | 7.98 | |||
| Current Valuation | 1.52 B | |||
| Price To Book | 0.95 X | |||
| Price To Sales | 8.38 X | |||
| Revenue | 114.07 M | |||
| EBITDA | 99.22 M | |||
| Net Income | 72.78 M | |||
| Total Debt | 683.88 M | |||
| Cash Flow From Operations | 88.58 M | |||
| Market Capitalization | 897.9 M | |||
| Total Asset | 1.66 B | |||
| Z Score | 0.6 | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 1.66 B | |||
| Last Dividend Paid | 0.077 |
About Al Aqar Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Al Aqar Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Al Aqar using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Al Aqar Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in 5116 Stock
Al Aqar financial ratios help investors to determine whether 5116 Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 5116 with respect to the benefits of owning Al Aqar security.